JPMORGAN CHASE & CO - VIVEVE MED INC ownership

VIVEVE MED INC's ticker is VIVE and the CUSIP is 92852W204. A total of 56 filers reported holding VIVEVE MED INC in Q1 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of VIVEVE MED INC
ValueSharesWeighting
Q2 2019$0
-100.0%
234
-94.3%
0.00%
Q1 2018$15,000
-42.3%
4,081
-22.9%
0.00%
Q4 2017$26,000
+420.0%
5,295
+506.5%
0.00%
Q3 2017$5,000
-96.7%
873
-95.8%
0.00%
Q2 2017$151,00020,9900.00%
Other shareholders
VIVEVE MED INC shareholders Q1 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,849,711$10,471,0006.36%
RTW INVESTMENTS, LP 2,861,023$7,782,0000.56%
Nantahala Capital Management 3,948,132$10,739,0000.44%
Granahan Investment Management 792,607$2,156,0000.13%
ACUTA CAPITAL PARTNERS, LLC 267,500$728,0000.13%
KNOTT DAVID M 71,449$194,0000.07%
WEXFORD CAPITAL LP 349,100$950,0000.06%
HighTower Advisors, LLC 1,821,456$4,957,0000.04%
MEITAV INVESTMENT HOUSE LTD 310,000$800,0000.04%
J. Goldman & Co LP 221,000$601,0000.03%
View complete list of VIVEVE MED INC shareholders